Science Corporation’s brain tech is valued at $3.5 billion following new funding
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
Science Corporation, a medical technology startup founded in 2021 by former Neuralink president Max Hodak, has raised a $400 million Series D funding round that values the company at $3.5 billion. Investors include Khosla Ventures, the Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator, and PLC Neurotech. The company's flagship product is PRIMA, a wearable and implantable chip designed to restore vision in patients with age-related macular degeneration, which is approved in Europe and currently being trialed for Stargardt disease. Science aims to introduce the device to the United States via the FDA's Humanitarian Device Exemption.
Continue in the app — vote & join in ➔Source: TechCrunch · via ahirlevel.hu